Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 33,469 $ 128,556
Restricted cash and cash equivalents—current 4,978 30,142
Accounts receivable, net 2,188 8,397
Inventory 1,535 28,242
Prepaid expenses and other current assets 22,615 33,778
Total current assets 64,785 229,115
Restricted cash and cash equivalents—non current 598 1,203
Vehicle deposits 48,783 117,071
Vehicles, net 100,088 118,949
Goodwill 0 121,169
Other assets 11,402 9,754
Total assets 225,656 597,261
Current liabilities:    
Accounts payable 20,235 5,002
Accrued expenses 33,413 31,428
Deferred revenue 47,820 62,439
Notes payable—current 22,200 49,094
Other current liabilities 10,950 5,089
Total current liabilities 134,618 153,052
Notes payable—non current (including $30,100 of Convertible Senior Secured Notes measured at fair value) 56,205 0
Derivative liabilities 1,892 136,196
Other liabilities 7,831 6,282
Total liabilities 200,546 295,530
Commitments and contingencies (Note 15)
Stockholders’ Equity    
Class A common stock, $0.0001 par value, 1,000,000,000 authorized, and 262,695,741 and 238,089,017 shares issued and outstanding as of December 31, 2022 and 2021, respectively, and Class X common stock, $0.0001 par value, 50,000,000 shares authorized and 34,534,930 shares issued and outstanding as of December 31, 2022 and 2021 [1] 30 27
Additional paid-in capital [1] 1,572,576 1,475,300
Accumulated other comprehensive income [1] (7,621) 7,538
Accumulated deficit [1] (1,539,875) (1,181,134)
Total stockholders’ equity [1] 25,110 301,731
Total liabilities and stockholders’ equity $ 225,656 $ 597,261
[1] Shares of preferred stock and common stock have been retroactively restated to give effect to the Business Combination